Skip to main content
PharmaBlock Sciences (Nanjing), Inc. logo

PharmaBlock Sciences (Nanjing), Inc. — Investor Relations & Filings

Ticker · 300725 ISIN · CNE1000035K5 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,618 across all filing types
Latest filing 2024-10-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300725

About PharmaBlock Sciences (Nanjing), Inc.

https://www.pharmablock.com

PharmaBlock Sciences (Nanjing), Inc. specializes in the design and manufacture of innovative building blocks and provides integrated chemistry services for drug discovery and development. The company offers a comprehensive portfolio of structurally diverse scaffolds and intermediates used to enhance the efficiency of medicinal chemistry. Its core capabilities include process research and development, scale-up production, and commercial-scale manufacturing under CDMO frameworks. By utilizing advanced chemical technologies and a vast library of unique chemical entities, the company supports global biotechnology and pharmaceutical organizations in streamlining their research pipelines and optimizing the transition from discovery to clinical development and commercialization.

Recent filings

Filing Released Lang Actions
关于新增2024年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding the addition of expected related party transactions for the fiscal year 2024. It details the nature, amounts, and parties involved in these related transactions, along with approvals from the board and independent directors. The document does not contain financial statements or comprehensive financial data but rather focuses on corporate governance and compliance related to related party transactions. It is not an annual or interim report, audit report, or earnings release. It is also not a proxy statement or voting result announcement. The content fits best with a Regulatory Filing (RNS) as it is a regulatory disclosure about related party transactions and approvals, which is a common type of regulatory announcement in corporate filings.
2024-10-29 Chinese
华泰联合证券有限责任公司关于南京药石科技股份有限公司新增2024年度日常关联交易预计的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from Huatai United Securities regarding the verification opinion on the newly added 2024 annual expected daily related-party transactions of Nanjing Yaoshi Technology Co., Ltd. It includes specifics about the related-party transactions, their amounts, pricing principles, related parties, and independent directors' opinions. The document references regulatory rules from the Shenzhen Stock Exchange and company bylaws, and it is focused on compliance and disclosure of related-party transactions. It does not contain financial statements or comprehensive financial performance data, nor is it a transcript, presentation, or voting result. It is a regulatory announcement about related-party transactions and their approval process, which fits best under Regulatory Filings (RNS) as it is a compliance disclosure that does not fit other specific categories like Annual Report or Interim Report. The document length is 3284 characters, which is relatively short and consistent with a regulatory announcement rather than a full report.
2024-10-29 Chinese
2024年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '南京药石科技股份有限公司2024 年第三季度报告' which translates to 'Nanjing Yaoshi Technology Co., Ltd. 2024 Third Quarter Report'. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the third quarter of 2024. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for the period. It is not an announcement of a report publication but the report itself, and it is not audited. The content matches the definition of an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year with substantive financial data and analysis.
2024-10-29 Chinese
关于吸收合并全资子公司的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the absorption merger of a wholly-owned subsidiary by the parent company. It details the board meeting approval, the merger method, the companies involved, and the impact of the merger. There are no financial statements or comprehensive financial performance data presented, only summary financial indicators. The document is a formal corporate announcement about a corporate restructuring event rather than a full financial report or detailed management discussion. It does not fit categories like Annual Report, Interim Report, or M&A filings that require merger proposals or tender offers. It is not a regulatory certification or voting result. The best fitting category is a Regulatory Filing (RNS) as it is a general regulatory announcement about a corporate action that does not fall into more specific categories.
2024-10-29 Chinese
第三届董事会第三十七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 37th meeting of the third board of directors of Nanjing Yaoshi Technology Co., Ltd. It includes details about the meeting date, voting results, and decisions made, such as approval of the 2024 Q3 report, related party transactions, amendments to stock trading management rules for directors and executives, and approval of a merger with a wholly owned subsidiary. The document repeatedly states that detailed content is available on the official disclosure website, indicating this is a meeting resolution announcement rather than the full report or detailed financial data. The document length is short (1811 characters) and primarily serves as a formal board meeting resolution announcement. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board or senior management. It is not a full financial report, audit report, or earnings release, nor is it a proxy statement or voting result declaration. Therefore, the correct classification is MANG with high confidence.
2024-10-29 Chinese
关于2024年第三季度可转债转股情况的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the conversion of convertible bonds into shares during the third quarter of 2024. It details the number of bonds converted, the remaining convertible bonds, the adjusted conversion prices over time, and changes in shareholding structure. It references regulatory approvals and stock exchange rules related to convertible bonds. The document is relatively short (3528 characters) and focuses on reporting the bond conversion and share changes for the quarter, without providing comprehensive financial statements or detailed financial analysis. This fits the category of a Capital/Financing Update (CAP), as it updates on the company's convertible bond conversions and capital structure changes during the quarter.
2024-10-08 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.